Skip to main content
Clinical and Experimental Immunology logoLink to Clinical and Experimental Immunology
. 1983 Mar;51(3):511–516.

Decreased TCGF activity in the culture medium of PHA stimulated peripheral mononuclear cells from patients with metastatic cancer.

E Nakayama, S Asano, N Takuwa, J Yokota, S Miwa
PMCID: PMC1536770  PMID: 6602018

Abstract

Activities of T cell growth factor (TCGF) of conditioned media from PHA stimulated cultures of peripheral mononuclear cells (PHA-MNC-CM) were compared among patients with cancer, patients with non-malignant disease and normal persons. In nine out of 10 cases of cancer with metastasis (including extensive infiltration to surrounding tissues), the activities were much lower than normal persons, whereas in four out of five cases of cancer without metastasis, the activities were almost the same as those of normal persons. The low activities of PHA-MNC-CM from patients with metastatic cancer were not due to the older age of patients, nor did it seem to be attributed to the malnutritional state of patients. When we examined the activity using non-adherent MNC instead of the whole MNC, the activities in patients with metastatic cancer rose up to almost the normal levels. In normal persons the decline of the activities after 3 days of culture were not observed after the removal of adherent cells. Our data indicate that the adherent cells have a suppressive effect on TCGF production in both normal persons and cancer patients, but that the effect may be exaggerated in patients with metastatic cancer.

Full text

PDF
511

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Alvarez J. M., Silva A., de Landazuri M. O. Human T cell growth factor. I. Optimal conditions for its production. J Immunol. 1979 Sep;123(3):977–983. [PubMed] [Google Scholar]
  2. Asano S., Goodyear M., Burns G. F., Bartlett P. F., MacKay I. R. Colony formation by T-lymphocytes infiltrating human tumours. Immunol Lett. 1981 Apr;3(1):17–19. doi: 10.1016/0165-2478(81)90089-4. [DOI] [PubMed] [Google Scholar]
  3. Asano S., Mandel T. E. Colonies formed in agar from human breast cancer and their identification as T-lymphocytes. J Natl Cancer Inst. 1981 Jul;67(1):25–32. [PubMed] [Google Scholar]
  4. Cheever M. A., Greenberg P. D., Fefer A., Gillis S. Augmentation of the anti-tumor therapeutic efficacy of long-term cultured T lymphocytes by in vivo administration of purified interleukin 2. J Exp Med. 1982 Apr 1;155(4):968–980. doi: 10.1084/jem.155.4.968. [DOI] [PMC free article] [PubMed] [Google Scholar]
  5. Garrigues H. J., Romero P., Hellström I., Hellström K. E. Adherent cells (macrophages?) in tumor-bearing mice suppress MLC responses. Cell Immunol. 1981 May 1;60(1):109–118. doi: 10.1016/0008-8749(81)90252-5. [DOI] [PubMed] [Google Scholar]
  6. Gillis S., Watson J. Interleukin-2 dependent culture of cytolytic T cell lines. Immunol Rev. 1981;54:81–109. doi: 10.1111/j.1600-065x.1981.tb00435.x. [DOI] [PubMed] [Google Scholar]
  7. Gullberg M., Ivars F., Coutinho A., Larsson E. L. Regulation of T cell growth factor production: arrest of TCGF production after 18 hours in normal lectin-stimulated mouse spleen cell cultures. J Immunol. 1981 Aug;127(2):407–411. [PubMed] [Google Scholar]
  8. Inouye H., Hank J. A., Alter B. J., Bach F. H. TCGF production for cloning and growth of functional human T lymphocytes. Scand J Immunol. 1980;12(2):149–154. doi: 10.1111/j.1365-3083.1980.tb00051.x. [DOI] [PubMed] [Google Scholar]
  9. Morgan D. A., Ruscetti F. W., Gallo R. Selective in vitro growth of T lymphocytes from normal human bone marrows. Science. 1976 Sep 10;193(4257):1007–1008. doi: 10.1126/science.181845. [DOI] [PubMed] [Google Scholar]
  10. Penn I. Depressed immunity and the development of cancer. Clin Exp Immunol. 1981 Dec;46(3):459–474. [PMC free article] [PubMed] [Google Scholar]
  11. Zembala M., Mytar B., Popiela T., Asherson G. L. Depressed in vitro peripheral blood lymphocyte response to mitogens in cancer patients: the role of suppressor cells. Int J Cancer. 1977 May 15;19(5):605–613. doi: 10.1002/ijc.2910190503. [DOI] [PubMed] [Google Scholar]

Articles from Clinical and Experimental Immunology are provided here courtesy of British Society for Immunology

RESOURCES